{
    "patient": {
        "Name": "Jennifer Houston",
        "DateOfBirth": "1996-08-11",
        "Sex": "Female",
        "Diagnosis": "Chronic myeloid leukemia (CML)",
        "BodyPart": "Leukemia",
        "Physician": "Dr. Christopher Reynolds",
        "TreatingInstitution": "White, Jones and Carlson"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Leukemia",
            "CollectedDate": "2024-03-08",
            "ReceivedDate": "2024-03-14",
            "TumorPercentage": "50%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2024-03-12",
            "ReceivedDate": "2024-03-12"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "ARID2",
                "DNA Alteration": " c.798G>A",
                "GeneMutation": " p.W266* Stopgain-LOF",
                "VariantAlleleFraction": "5.87%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "CALR",
                "DNA Alteration": "c.1154_1155insTTGTC",
                "GeneMutation": "p.L367fs*46 Spliceregionvariant-LOF",
                "VariantAlleleFraction": "10.76%"
            },
            {
                "Gene": "CSF3R",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": " p.W266* Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "25.98%"
            },
            {
                "Gene": "CDC73",
                "DNA Alteration": "c.1A>G",
                "GeneMutation": " p.W266* Stopgain-LOF",
                "VariantAlleleFraction": "17.65%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "PTCH1",
            "PDGFRB",
            "SF3B1",
            "CALR"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "41 m/Mb",
            "Tmbpercentile": "23%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}